Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome

Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy

(2011) Babafemi Taiwo et al.   JOURNAL OF INFECTIOUS DISEASES

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

(2010) Hiroyu Hatano et al.   AIDS

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

(2010) Stéphanie Haïm-Boukobza et al.   AIDS

Antiretroviral Treatment of Adult HIV Infection

(2010) Melanie A. Thompson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Detection of HIV-1 at between 20 and 49 Copies per Milliliter by the Cobas TaqMan HIV-1 v2.0 Assay Is Associated with Higher Pretherapy Viral Load and Less Time on Antiretroviral Therapy

(2010) J. F. Pascual-Pareja et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The significance of very low-level viraemia detected by sensitive viral load assays in HIV infected patients on HAART

(2010) John Widdrington et al.   JOURNAL OF INFECTION

Poor Agreement between 2 Assays for Measuring Low Levels of HIV‐1 Viral Load

(2009) Julio S. G. Montaner et al.   CLINICAL INFECTIOUS DISEASES

Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation

(2009) Stefano Bonora et al.   JOURNAL OF MEDICAL VIROLOGY

The Challenge of Finding a Cure for HIV Infection

(2009) D. D. Richman et al.   SCIENCE

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

(2008) S. Palmer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA